The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) ROCE % : 0.00% (As of . 20)

View and export this data going back to . Start your Free Trial

What is The IBN SINA Pharmaceutical Industry ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. The IBN SINA Pharmaceutical Industry's annualized ROCE % for the quarter that ended in . 20 was 0.00%.

The IBN SINA Pharmaceutical Industry ROCE % Historical Data

The historical data trend for The IBN SINA Pharmaceutical Industry's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The IBN SINA Pharmaceutical Industry ROCE % Chart

The IBN SINA Pharmaceutical Industry Annual Data

Trend

ROCE %

The IBN SINA Pharmaceutical Industry Semi-Annual Data

ROCE %

The IBN SINA Pharmaceutical Industry ROCE % Calculation

The IBN SINA Pharmaceutical Industry's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

The IBN SINA Pharmaceutical Industry's ROCE % of for the quarter that ended in . 20 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: . 20 )		(Q: . 20 )		(Q: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: . 20 )		(Q: . 20 )		(Q: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

(1) Note: The EBIT data used here is one times the annual (. 20) EBIT data.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

The IBN SINA Pharmaceutical Industry ROCE % Related Terms

Thank you for viewing the detailed overview of The IBN SINA Pharmaceutical Industry's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

The IBN SINA Pharmaceutical Industry Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The IBN SINA Pharmaceutical Industry PLC (DHA:IBNSINA) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207

Website

https://www.ibnsinapharma.com

The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.

The IBN SINA Pharmaceutical Industry Headlines

No Headlines